A genome-wide association study has identified two new loci modifying pulmonary disease severity in cystic fibrosis. Although this data offers clues to pathways influencing pulmonary function, the underlying genes and mechanisms remain to be elucidated.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Riordan, J.R. et al. Science 245, 1066–1073 (1989).
Kerem, B.S. et al. Science 245, 1073–1080 (1989).
Wright, F.A. et al. Nat. Genet. 43, 539–546 (2011).
Riordan, J.R. Annu. Rev. Physiol. 55, 609–630 (1993).
Cystic Fibrosis Genotype-Phenotype Consortium. N. Engl. J. Med. 329, 1308–1313 (1993).
Lester, L.A. et al. Pediatrics 93, 114–118 (1994).
Koch, C. et al. Pediatr. Pulmonol. 31, 1–12 (2001).
Cutting, G.R. Ann. NY Acad. Sci. 1214, 57–69 (2010).
Garred, P. et al. J. Clin. Invest. 104, 431–437 (1999).
Gabolde, M. et al. Br. Med. J. 319, 1166–1167 (1999).
Madsen, H.O. et al. Immunogenetics 40, 37–44 (1994).
Drumm, M.L. et al. N. Engl. J. Med. 353, 1443–1453 (2005).
Gu, Y. et al. Nature 458, 1039–1042 (2009).
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Witt, H. New modifier loci in cystic fibrosis. Nat Genet 43, 508–509 (2011). https://doi.org/10.1038/ng.844